Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Hepatitis C Virus Prevalence and Genotyping among Hepatocellular Carcinoma Patients in Baghdad

  • Published : 2014.10.11
Download PDF
⟨ Previous Next ⟩

Abstract

Hepatocellular carcinoma (HCC) is the third most common cause for cancer death in the world, now being especially linked to chronic hepatitis C virus (HCV) infection. This case-control study consisting of 65 HCC patients and 82 patients with other malignant tumours as controls was conducted to determine the association of HCV markers with HCC. Serum of each participant was obtained for detection of HCV Ab and RNA by DNA enzyme immunoassay (DEIA). Twenty six per cent (26.0%) of HCC patients had positive anti-HCV which was significantly greater than the control group (p=0.001). HCC patients significantly have a risk of exposure to HCV infection almost 3 times than the control group (OR=2.87, 95% C.I=1.1-7). Anti-HCV seropositive rate was significantly (p=0.03) higher among old age HCC patients and increases with age. Males with HCC significantly showed to have more than 9 times risk of exposure to HCV infection (OR=9.375, 95 % CI=1.299-67.647) than females. HCV-RNA seropositive rate was (70.8%) significantly higher among HCC patients compared to (22.2%) the control group (p=0.019). The most prevalent genotype (as a single or mixed pattern of infection) was HCV-1b. This study detected a significantly higher HCV seropositive rate of antibodies and RNA in HCC patients.

Keywords

References

  1. Abd El-Rahman NZ, Nabawy Z, Auhood AMN, et al (2013). Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation. Asian Pac J Cancer Prev, 14, 6721-26. https://doi.org/10.7314/APJCP.2013.14.11.6721
  2. Aghemo A and Colombo M (2013). Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside. Semin Immunopathol, 35, 111-20. https://doi.org/10.1007/s00281-012-0330-z
  3. Al Kubaisy W (1998). Epidemiology and genotypic distribution of hepatitis C in Iraqi pregnant women. Thesis for degree of doctor in philosophy. Baghdad-Iraq.
  4. Altekruse SF, McGlynn KA, Reichman ME (2009). Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol, 27, 1485-91. https://doi.org/10.1200/JCO.2008.20.7753
  5. Amal AM, Samah AL, James DC, Abdel Gawad MH, Ibrahem S (2011). Chronic hepatitis C genotype-4 infection: role of insulin resistance in hepatocellular carcinoma. Virology J, 8, 496. https://doi.org/10.1186/1743-422X-8-496
  6. Anita C, Gaurav D, Vikas V, Amit PS (2011). Distribution pattern of HCV genotypes and its association with viral load. Indian J Med Res, 133, 326-31.
  7. Berry V, Arora R, Paul P (2005). Hepatitis C-clinical outcome and. diagnosis. J K Sci, 7, 129-32.
  8. Chayama K, Tsubota A, Kobayashi M, et al (1997). Pretreatment virus load and multiple amino acid substitution in the interferon treatment in patients with chronic genotypes 1b hepatitis C virus infection. Hepatology, 25, 745-9. https://doi.org/10.1002/hep.510250342
  9. David RM, Stanley ML (2011). Virus-specific Mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene, 28, 1969-83.
  10. Denis S, Abdelouahid EK, Hanan G, et al (2012). Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies. World J Hepatol, 4, 342-55.
  11. Donato F, Tagger A, Gelatti U, et al (2002). Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol, 155, 323-31. https://doi.org/10.1093/aje/155.4.323
  12. El-Serag HB, Mason AC (2000). Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med.;160 (21): 3227-30. https://doi.org/10.1001/archinte.160.21.3227
  13. El-Serag HB, Rudolph KL (2007). Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132, 2557-76. https://doi.org/10.1053/j.gastro.2007.04.061
  14. El-Serag HB (2002). Hepatocellular carcinoma and hepatitis C in the United States. Hepatology, 36, 74-83.
  15. Esaki T, Suzuki N, Yokoyama K, et al (2004). Hepatocellular carcinoma in a patient with liver cirrhosis associated with negative serum HCV tests but positive liver tissue HCV RNA. Intern Med, 43, 279-82. https://doi.org/10.2169/internalmedicine.43.279
  16. Farinati F, Cardin R, Bortolami M, et al (2007). Hepatitis C virus: From oxygen free radicals to hepatocellular carcinoma. J Viral Hepat, 14, 821-9.
  17. Farrell G (2002). Hepatitis C, other liver disorders, and liver health: a practical guide. sydney: maclennan and petty.
  18. Fujioka S, Shimomura H, Iwasaki Y, et al (2003). Hepatitis B virus gene in liver tissue promotes hepatocellular carcinoma development in chronic hepatitis C patients. Dig Dis Sci, 48, 1920-4. https://doi.org/10.1023/A:1026153800896
  19. Hirakawa M, Ikeda K, Arase Y, et al (2008). Hepatocarcinogenesis following HCV RNA eradication by interferon in chronic hepatitis patients. Intern Med, 47, 1637-43. https://doi.org/10.2169/internalmedicine.47.1087
  20. Hossein K, Mehdi F, Seyed HRM, Hamid RM (2012). Hepatitis C virus-proteins, diagnosis, treatment and new approaches for vaccine development. Asian Pac J Cancer Prev, 13, 5917-35. https://doi.org/10.7314/APJCP.2012.13.12.5917
  21. Jen-Eing J, Meng-Feng T, Hey-Ru T, et al (2014). Impact of hepatitis B and hepatitis C on adverse hepatitis fibrosis in hepatocellular carcinoma related to betel quid chewing. Asian Pac J Cancer Prev, 15, 637-42. https://doi.org/10.7314/APJCP.2014.15.2.637
  22. Jian-Ying Z, Min D, Xiao W, et al (1998). A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. Int J Epidemiol, 27, 574-8. https://doi.org/10.1093/ije/27.4.574
  23. Jin-Hu F, Jian-Bing W, Yong J, et al (2013). Attributable causes of liver cancer. Asian Pac J Cancer Prev, 14, 7251-56. https://doi.org/10.7314/APJCP.2013.14.12.7251
  24. Kazuo T, Shoji T (1997). Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alonine aminotransferase levels in hepatoctomized patient with hepatitis C virus associated cirrhosis and HCC. Cancer, 79, 688-94. https://doi.org/10.1002/(SICI)1097-0142(19970215)79:4<688::AID-CNCR5>3.0.CO;2-A
  25. Kew MC, Yu MC, Kedda MA, et al (1997). The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks. Gastroenterology, 112, 184-7. https://doi.org/10.1016/S0016-5085(97)70233-6
  26. Koike K (2007). Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways. J Gastroenterol Hepatol, 22, 108-11. https://doi.org/10.1111/j.1440-1746.2006.04669.x
  27. Levrero M (2006). Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene, 25, 3834-47. https://doi.org/10.1038/sj.onc.1209562
  28. Lindenbach BD, Thiel HJ, Rice CM (2007). Flaviviridae: the viruses and their replication. in: knipe DM, howley PM, editors. fields virology. 5th ed. philadelphia: lippincott-raven.
  29. Lok AS (2011). Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C. Gastroenterology, 140, 840-9. https://doi.org/10.1053/j.gastro.2010.11.050
  30. Moutaz D, Aliaa A (2009). Hepatocellular carcinoma in hepatitis c genotype 4 after viral clearance and in absence of cirrhosis: two case reports. Case Report Cases J, 2, 7927.
  31. Nelson PK, Mathers BM, Cowie B, et al (2011). Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet, 378, 571-83. https://doi.org/10.1016/S0140-6736(11)61097-0
  32. Nishioka K, Watanabe J, Furuta S, et al (1991). A high prevalence of antibodies to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer, 67, 429-33. https://doi.org/10.1002/1097-0142(19910115)67:2<429::AID-CNCR2820670218>3.0.CO;2-#
  33. Nousbaum JB, Pol S, Nalpas B, et al (1995). Hepatitis C virus type 1b (II) infection in France and Italy. collaborative study group. Ann Intern Med, 122, 161-8. https://doi.org/10.7326/0003-4819-122-3-199502010-00001
  34. Parkin DM, Bray F, Ferlay J, Pisani P. (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
  35. Peng C, You C, Mei XS, et al (2012). Bicluster and pathway enrichment analysis of HCV-induced cirrhosis and hepatocellular carcinoma. Asian Pac J Cancer Prev, 13, 3741-45. https://doi.org/10.7314/APJCP.2012.13.8.3741
  36. Rathi PK, Lucinda LH, Lauren EE, Stanley ML, David RM (2011). Hepatitis C Virus Infection causes cell cycle arrest at the level of initiation of mitosis. J Virol, 85, 7989-8001. https://doi.org/10.1128/JVI.00280-11
  37. Rivas-Estilla AM, Cordero-Perez P, Trujillo-Murillo KC, et al (2008). Genotyping of hepatitis C virus (HCV) in infected patients from Northeast Mexico. Ann Hepatol, 7, 144-7.
  38. Ruiz J, Sangro B, Cuende JI, et al (1992). Hepatitis B and C viral infections in patients with hepatocellular cardnoma. Hepatology, 16, 637-41. https://doi.org/10.1002/hep.1840160305
  39. Samreen B, Khaliq S, Ashfaq UA, et al (2012). Hepatitis C virus entry: role of host and viral factors. Infect Genet Evol, 12, 1699-709. https://doi.org/10.1016/j.meegid.2012.07.010
  40. Sangiovanni A, Del Ninno E, Fasani P, et al (2004). Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology, 126, 1005-14. https://doi.org/10.1053/j.gastro.2003.12.049
  41. Savino B, Daniela S, Piero LA, et al (2011). Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus. Hepat Med, 3, 21-8.
  42. Sherman M (2005). Hepatocellular carcinoma: epidemiology, risk factors and screening. Semin Liver Dis, 25, 143-54. https://doi.org/10.1055/s-2005-871194
  43. Shiratori Y, Imazeki F, Moriyama M, et al (2000). Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann Intern Med, 132, 517-24.
  44. Simmonds P, Alberti A, Alter HJ, et al (1994). A proposal system for the nomenclature of hepatitis C viral genotypes. Hepatology, 19, 1321-4. https://doi.org/10.1002/hep.1840190538
  45. Takano S, Yokosuka O, Imazeld F, et al (1995). Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology, 21, 650-5. https://doi.org/10.1002/hep.1840210308
  46. Takeshi T, Kazuhiro N, Akiko S, et al (2012). Genetic risk of hepatocellular carcinoma in patients with hepatitis C virus : a case control study. J Gastroenterol Hepatol, 27, 797-804. https://doi.org/10.1111/j.1440-1746.2011.06948.x
  47. Tanaka Y, Hanada K, Mizokami M, et al (2002). Inaugural article: a comparison of the molecular clock of hepatitis C virus in the US and Japan. Proc Natl AcadSci USA, 99, 15584-9. https://doi.org/10.1073/pnas.242608099
  48. Tornesello ML, Buonaguro L, Tatangelo F, et al (2013). Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections. Genomics, 102, 74-83. https://doi.org/10.1016/j.ygeno.2013.04.001
  49. Willatt JM, Hussain HK, Adusumilli S, et al (2008). MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology, 247, 311-30. https://doi.org/10.1148/radiol.2472061331
  50. Yang JD, Roberts LR (2010). Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol, 7, 448-58. https://doi.org/10.1038/nrgastro.2010.100
  51. Yu MC, Tong MJ, Coursaget P, et al (1990). Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the US. J Natl Cancer Inst, 82, 1038-61. https://doi.org/10.1093/jnci/82.12.1038

Cited by

  1. The Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-Analysis vol.10, pp.8, 2015, https://doi.org/10.1371/journal.pone.0135281
  2. Interferon-γ and Interleukin-10 Gene Polymorphisms are not Predictors of Chronic Hepatitis C (Genotype-4) Disease Progression vol.16, pp.12, 2015, https://doi.org/10.7314/APJCP.2015.16.12.5025
  3. Evaluation of the Frequency of the IL-28 Polymorphism (rs8099917) in Patients with Chronic Hepatitis C Using Zip Nucleic Acid Probes, Kerman, Southeast of Iran vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.1919
  4. Preparation and Characterization of Anti-GP73 Monoclonal Antibodies and Development of Double-antibody Sandwich ELISA vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.2043
  5. Hepatitis C Virus Associated Hepatocellular Carcinoma Risk vol.16, pp.6, 2015, https://doi.org/10.7314/APJCP.2015.16.6.2585
  6. Age and gender distribution of Hepatitis C virus prevalence and genotypes of individuals of physical examination in WuHan, Central China vol.5, pp.1, 2016, https://doi.org/10.1186/s40064-016-3224-z